Back to Results
First PageMeta Content
Developmental biology / Cell biology / Bioengineering / Cloning / Tissue engineering / Regenerative medicine / Artificial organ / Allotransplantation / Regeneration / Biology / Medicine / Emerging technologies


Document Date: 2014-04-16 07:14:28

Open Document

File Size: 1,14 MB

Share Result on Facebook

Company

John Wiley & Sons Inc. / Electronics Engineers Inc. / HHS/HRSA / /

Country

United States / /

Event

Business Partnership / /

Facility

National Institute of Health / Scaffold Cellularization / /

IndustryTerm

clinical applications / potential applications / implantation site / end product applications / organ systems / encapsulation technology / end products / immunoisolation systems / mechanical devices / technology development / organ-like model systems / non biological devices / left ventricular assist devices / /

MedicalCondition

hyperplastic left heart syndrome / cardiovascular disorders / congenital defects / disease / atherosclerosis / chronic shortage / acute myocardial failure / end-stage heart failure / /

MedicalTreatment

liver transplants / surgery / /

Organization

National Institute of Health / National Science Foundation / UNOS / US Government / RI AL / Foundations mission / Minneapolis Medical Research Foundation / /

Person

M. V. Sefton / R. Nerem / J. P. Vacanti / P. Dunnill / A. Atala / R. Langer / C. Mason / Eugene Bell / Ravi Birla / /

Position

researcher / collaborative model for tissue engineering research / /

Technology

biomaterials / TISSUE ENGINEERING / transplantation / stem cells / regenerative medicine / apoptosis / specific technology / encapsulation technology / /

SocialTag